ATE482725T1 - Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen. - Google Patents

Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.

Info

Publication number
ATE482725T1
ATE482725T1 AT04758676T AT04758676T ATE482725T1 AT E482725 T1 ATE482725 T1 AT E482725T1 AT 04758676 T AT04758676 T AT 04758676T AT 04758676 T AT04758676 T AT 04758676T AT E482725 T1 ATE482725 T1 AT E482725T1
Authority
AT
Austria
Prior art keywords
cell
progressor
organ failure
based treatment
target
Prior art date
Application number
AT04758676T
Other languages
English (en)
Inventor
Christof Westenfelder
Original Assignee
Us Dept Of Veteran S Affaires
Univ Utah Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Dept Of Veteran S Affaires, Univ Utah Res Found filed Critical Us Dept Of Veteran S Affaires
Application granted granted Critical
Publication of ATE482725T1 publication Critical patent/ATE482725T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04758676T 2003-04-01 2004-03-31 Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen. ATE482725T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45955403P 2003-04-01 2003-04-01
US47517803P 2003-06-02 2003-06-02
PCT/US2004/009922 WO2004090112A2 (en) 2003-04-01 2004-03-31 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction

Publications (1)

Publication Number Publication Date
ATE482725T1 true ATE482725T1 (de) 2010-10-15

Family

ID=33162210

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04758676T ATE482725T1 (de) 2003-04-01 2004-03-31 Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.

Country Status (7)

Country Link
US (2) US8603462B2 (de)
EP (3) EP2263698A1 (de)
AT (1) ATE482725T1 (de)
AU (2) AU2004227342B2 (de)
CA (3) CA2809195C (de)
DE (1) DE602004029337D1 (de)
WO (1) WO2004090112A2 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE482725T1 (de) 2003-04-01 2010-10-15 Us Dept Of Veteran S Affaires Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
BRPI0520280A2 (pt) * 2005-05-10 2009-04-28 Us Of America Dept Of Veteran terapia de disfunÇÕes renais e falÊncia méltipla de àrgços com cÉlulas-tronco mesenquimais e meio condicionado por exposiÇço a cÉlulas-tronco mesenquimais
MX342474B (es) 2005-09-23 2016-09-30 Cellerix Sl Poblaciones celulares con actividad inmunoreguladora, método de aislamiento y usos.
WO2008036349A2 (en) 2006-09-19 2008-03-27 Insugen, Llc Fused stem cells useful for the treatment of diabetes and methods thereof
WO2008060788A2 (en) 2006-10-11 2008-05-22 The General Hospital Corporation Compositions, methods, and devices for treating liver disease
US20080125490A1 (en) * 2006-11-03 2008-05-29 My Svensson Treatment and prevention of cardiovascular disease in patients with chronic kidney disease by administering Omega-3 Fatty Acids
WO2008109674A2 (en) 2007-03-05 2008-09-12 Caridianbct, Inc. Cell expansion system and methods of use
US20110020291A1 (en) * 2007-11-17 2011-01-27 Debrabrata Banerjee Use of stem cells for wound healing
WO2009085216A2 (en) 2007-12-20 2009-07-09 Squicor Compositions and methods for detecting or elimninating senescent cells to diagnose or treat disease
US20090291061A1 (en) * 2008-05-21 2009-11-26 Riordan Neil H Stem cell therapy for blood vessel degeneration
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
US20100111908A1 (en) * 2008-11-03 2010-05-06 Fangming Lin Induction of Renal Cells for Treatment of Kidney Disease
JP2013506681A (ja) * 2009-10-02 2013-02-28 バクスター・インターナショナル・インコーポレイテッド 腎損傷の処置における使用のための造血幹細胞
US20120269779A1 (en) * 2009-10-30 2012-10-25 Allocure, Inc. Mesenchymal stromal cell populations and methods of using same
US8822218B2 (en) * 2009-12-04 2014-09-02 Stem Cell & Regenerative Medicine International, Inc. Method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts
US9057045B2 (en) 2009-12-29 2015-06-16 Terumo Bct, Inc. Method of loading and distributing cells in a bioreactor of a cell expansion system
CN103180435A (zh) * 2010-08-31 2013-06-26 库克通用生物技术有限责任公司 用于治疗动物疾病的全身的同种异体干细胞疗法
WO2012040408A2 (en) * 2010-09-23 2012-03-29 Children's Medical Center Corporation Engineered vascular adipose tissue
WO2012048275A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
US20130287747A1 (en) * 2012-04-30 2013-10-31 Allocure, Inc. Methods of Treating Acute Kidney Injury Using Mesenchymal Stem Cells
CN104540933A (zh) 2012-08-20 2015-04-22 泰尔茂比司特公司 在细胞扩增系统的生物反应器中加载和分配细胞的方法
CN105793411B (zh) 2013-11-16 2018-04-17 泰尔茂比司特公司 生物反应器中的细胞扩增
JP2015160820A (ja) * 2014-02-26 2015-09-07 株式会社Ｃｌｉｏ 慢性腎障害治療のための多能性幹細胞
JP6783143B2 (ja) 2014-03-25 2020-11-11 テルモ ビーシーティー、インコーポレーテッド 培地の受動的補充
WO2015164808A1 (en) 2014-04-24 2015-10-29 Terumo Bct, Inc. Measuring flow rate
JP6779866B2 (ja) 2014-06-13 2020-11-04 チルドレンズ メディカル センター コーポレイション ミトコンドリアを単離するための製品および方法
US20160090569A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled Feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017095946A1 (en) 2015-11-30 2017-06-08 Flagship Pioneering, Inc. Methods and compositions relating to chondrisomes
FI4272834T3 (fi) * 2016-01-15 2025-12-05 Childrens Medical Ct Corp Mitokondrioiden ja yhdistettyjen mitokondriaalisten aineiden terapeuttinen käyttö
KR20180102661A (ko) 2016-01-21 2018-09-17 에이비티 홀딩 컴퍼니 상처 치유를 위한 줄기 세포
GB201604304D0 (en) 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11629332B2 (en) 2017-03-31 2023-04-18 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
CN108646035B (zh) * 2018-05-18 2021-06-11 北京亦科诺生物科技有限公司 胰岛素样生长因子1的新应用
JP2022517531A (ja) * 2019-01-18 2022-03-09 アブラハム ジェイ アンド フィリス カッツ コード ブラッド ファウンデーション 神経学的疾患のための二重幹細胞治療
EP4076535A4 (de) * 2019-12-19 2024-04-17 University of Miami Verabreichung von stammzellen
WO2021226373A2 (en) 2020-05-08 2021-11-11 Gallant Pet, Inc. Uterine-derived regenerative cell compositions and uses thereof
EP4314244B1 (de) 2021-03-23 2025-07-23 Terumo BCT, Inc. Zellerfassung und -erweiterung
US12152699B2 (en) 2022-02-28 2024-11-26 Terumo Bct, Inc. Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US459554A (en) 1891-09-15 Fence-wire stretcher
US475178A (en) 1892-05-17 Electrical forge
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5811094A (en) * 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5837539A (en) * 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5226914A (en) * 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5733542A (en) * 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
US6010696A (en) * 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5197985A (en) * 1990-11-16 1993-03-30 Caplan Arnold I Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
US5876708A (en) * 1992-02-19 1999-03-02 The General Hospital Corporation Allogeneic and xenogeneic transplantation
US5591625A (en) * 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
CA2192103C (en) * 1994-06-06 2002-02-05 Arnold I. Caplan Biomatrix for tissue regeneration
US6174333B1 (en) * 1994-06-06 2001-01-16 Osiris Therapeutics, Inc. Biomatrix for soft tissue regeneration using mesenchymal stem cells
US5736396A (en) * 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5643736A (en) * 1995-02-06 1997-07-01 Osiris Therapeutics, Inc. Monoclonal antibodies for human osteogenic cell surface antigens
US5908782A (en) * 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
ATE288480T1 (de) * 1995-11-16 2005-02-15 Univ Case Western Reserve Chondrogene in vitro induktion von menschlichen mensenchymalen stammzellen
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
CA2251983C (en) * 1996-04-19 2003-12-16 Sudhakar Kadiyala Regeneration and augmentation of bone using mesenchymal stem cells
US5827740A (en) * 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
CA2271758A1 (en) * 1996-11-15 1998-05-22 Osiris Therapeutics, Inc. Msc-megakaryocyte precursor composition and method of isolating mscs associated with isolated megakaryocytes by isolating megakaryocytes
ES2285779T3 (es) * 1997-07-03 2007-11-16 Osiris Therapeutics, Inc. Celulas madre mesenquimatosas humanas de sangre periferica.
ATE307195T1 (de) * 1997-07-14 2005-11-15 Osiris Therapeutics Inc Herzmuskelregenerierung unter verwendung mesenchymaler stammzellen
AU9127098A (en) * 1997-09-04 1999-03-22 Osiris Therapeutics, Inc. Ligands that modulate differentiation of mesenchymal stem cells
AU9231998A (en) * 1997-09-20 1999-04-12 Osiris Therapeutics, Inc. Antigen presenting mesenchymal stem cells
AU9513898A (en) * 1997-10-03 1999-04-27 Osiris Therapeutics, Inc. Human hox c10 and polynucleotides encoding
US6429012B1 (en) * 1997-10-06 2002-08-06 Viacell, Inc. Cell population containing non-fetal hemangioblasts and method for producing same
AU1203999A (en) * 1997-10-31 1999-05-24 Osiris Therapeutics, Inc. Human slit polypeptide and polynucleotides encoding same
PT1062321E (pt) * 1998-03-13 2005-05-31 Osiris Therapeutics Inc Utilizacoes para celulas estaminais mesenquimais humanas nao autologas
US6368636B1 (en) * 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
EP1066052B1 (de) * 1998-03-18 2006-02-01 Osiris Therapeutics, Inc. Mesenchymale stammzellen für die prävention und behandlung von immunantworten bei transplantationen
CA2328425A1 (en) * 1998-05-22 1999-12-02 Osiris Therapeutics, Inc. Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells
ES2292245T3 (es) * 1998-05-29 2008-03-01 Osiris Therapeutics, Inc. Celulas madre mesenquimaticas cd45+ y/o fibroblasto+humanas.
DK1084230T3 (da) * 1998-06-08 2008-03-03 Osiris Therapeutics Inc Regulering af hæmatopoietisk stamcelledifferentiering ved anvendelse af humane mesenkymstamceller
JP4526186B2 (ja) * 1998-06-08 2010-08-18 オシリス セラピューティクス，インコーポレイテッド 造血幹細胞を試験管内で維持する方法と組成物
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6239157B1 (en) * 1999-09-10 2001-05-29 Osiris Therapeutics, Inc. Inhibition of osteoclastogenesis
US6685936B2 (en) * 1999-10-12 2004-02-03 Osiris Therapeutics, Inc. Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation
US20020151496A1 (en) * 2000-12-08 2002-10-17 Bringmann Peter W. Novel fibroblast growth factors
JP4358621B2 (ja) * 2001-08-08 2009-11-04 泰彦 田畑 細胞と細胞増殖因子とからなる腎臓の再生のための材料
AU2003225791A1 (en) * 2002-03-15 2003-09-29 Department Of Veterans Affairs, Rehabilitation R And D Service Methods and compositions for directing cells to target organs
EP1562636A4 (de) 2002-11-05 2007-01-31 Brigham & Womens Hospital Mesenchymale stammzellen und anwendungsverfahren dafür
US20040258670A1 (en) * 2002-12-05 2004-12-23 Case Western Reserve University Cell-based therapies for ischemia
ATE482725T1 (de) 2003-04-01 2010-10-15 Us Dept Of Veteran S Affaires Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.

Also Published As

Publication number Publication date
EP2335738A1 (de) 2011-06-22
EP1608411A2 (de) 2005-12-28
CA2521217A1 (en) 2004-10-21
US8603462B2 (en) 2013-12-10
EP1608411B1 (de) 2010-09-29
WO2004090112A3 (en) 2005-03-10
CA2784829C (en) 2015-10-06
AU2011200017A1 (en) 2011-01-27
CA2784829A1 (en) 2004-10-21
EP1608411A4 (de) 2007-08-29
CA2809195A1 (en) 2004-10-21
US20140086886A1 (en) 2014-03-27
US20070178071A1 (en) 2007-08-02
EP2263698A1 (de) 2010-12-22
WO2004090112A2 (en) 2004-10-21
AU2011200017B2 (en) 2012-04-19
CA2521217C (en) 2013-05-14
AU2004227342B2 (en) 2011-01-20
AU2004227342A1 (en) 2004-10-21
WO2004090112B1 (en) 2005-04-21
DE602004029337D1 (de) 2010-11-11
CA2809195C (en) 2014-05-20

Similar Documents

Publication Publication Date Title
ATE482725T1 (de) Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.
WO2006121445A3 (en) Therapy of kidney diseases and multiorgan failure with mesenchymal stem cells and mesenchymal stem cell conditioned media
ATE482712T1 (de) Überstände von mesenchymstammzellen zur vorbeugung und behandlung von immunantworten in transplantationen
EP2298862A3 (de) Mesenchymale Stammzellen und deren Verwendungen
EA200900272A1 (ru) Комбинации для лечения заболеваний, связанных с клеточной пролиферацией, миграцией или апоптозом клеток миеломы или с ангиогенезом
GB2434157A (en) Platelets from stem cells
PE20070244A1 (es) Biotejido de colageno derivado de placenta para el tratamiento de ulceras en la pierna
DK1699915T3 (da) Anvendelse af erythropoietin til levervævsregenerering
EA200400482A1 (ru) Кератиноциты, пригодные для применения в качестве биологически активной субстанции при лечении ран
DE60118604D1 (de) Photosensibilisator-enthaltende lagerungslösung zur inaktivierung von biologischen verunreinigungen
MXPA02007137A (es) Fuente de tejido hepatico.
ECSP045085A (es) Stent o injerto vascular recubierto con inhibidores de la proteína tirosina quinasa y método de usar el mismo
WO2003085092A3 (en) Cellular transplantation for heart regeneration
ATE395924T1 (de) Wiederherstellung zerstörten gewebes mit hilfe von multipotenten zellen
DE122009000036I1 (de) Verwendung von Dapoxetin, A selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Disfunktion
EP1907014A4 (de) Chondrogene zusammensetzungen und anwendungsverfahren
ATE359798T1 (de) Verwendungvon dextransulfat zur behandlung von ibmir
WO2005120549A3 (en) Local delivery of growth factors for stem cell transplantation
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
NO2019032I1 (no) Treosulfan
ATE556134T1 (de) Mesenchymstammzellen und verwendungendafür
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis
ATE324905T1 (de) Verwendung von plgf zur vorbeugung oder behandlung von ischaemie oder schlaganfall
RU2004136472A (ru) Способ лечения хронических диффузных заболеваний печени
RU2007114245A (ru) Способ стимуляции коллатерального кровотока у больных с облитерирующим атеросклерозом артерий нижних конечностей

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties